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   Clinical evaluation of Uropyridin (the Eisai Pharmaceutical Co., phenylazo-diamino-
pyridine HC1) as an allopathic agent for the irritable bladder syndrome have been under-
taken. It is found that Uropyridin is effective in quick relief of the irritable bladder 
syndrome and when the syndrome is persistent and it is not relieved by the  other, drugs 
or allopathic treatment. Uropyridin in combination with chemotherapy or antibiotic the-
rapy is capable of improving symptoms caused by bacterial cystitis. 
   Therapy with Uropyridin will be recommended on a dosage schedule of 150-200 mgm. 
three times daily. 
   According to our clinical trials with  Uropyridine, its indications are as follows 
1. Cystitis, urethritis, prostatitis and the irritable bladder syndrome in female whose 
objective findings is minimum while significant subjective complaints are present. 
2 Irritable bladder syndrome associated with hypertrophy of the prostate. 
3. Irritable bladder syndrome due to the ureteral stone or indwelling catheter. 
4. Analgesia for operative wound and the mucous membrane of the urinary tract after 
urological operation and diagnostic procedure. 
   Side effect encountered in our 22 cases was nausea which  occurred in only one case 
with the irritable bladder. 
   Since patient's urine on this therapy is orange colored, it is advised to inform them 
that the coloring is due to Uropyridin administration. 
   In the United States, 1% solution of Uropyridin is widely utilyzed for the purpose of 
surface anesthesia for urological  instrumentation in children. Authors suggest that it is 
also worth to put on trial.




























































































服用当 日よりカテーテルによる刺戟症状著 し く緩 解
し,使用以前 と異 り夜聞安眠することが可 能 とな つ
た.他 の1例では症状が僅かではあるが減少した.
叉膀胱腫瘍に対し膀胱の部分切除術を行つた2例及
































































ているが,こ れも試みるに値するも の と考 え
る.
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悪心の為服用を中止
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